Elekta AB ser. B (EKTAb)

Currency in SEK
49.80
+0.36(+0.73%)
Closed·
EKTAb Scorecard
Full Analysis
Net income is expected to grow this year
High dividend Yield
Fair Value
Day's Range
49.1849.92
52 wk Range
44.5076.30
Key Statistics
Prev. Close
49.44
Open
49.5
Day's Range
49.18-49.92
52 wk Range
44.5-76.3
Volume
372.26K
Average Volume (3m)
1.28M
1-Year Change
-26.76%
Book Value / Share
23.04
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EKTAb Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
58.58
Upside
+17.62%
Members' Sentiments
Bearish
Bullish
ProTips
Valuation implies a strong free cash flow yield

Elekta AB ser. B News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Elekta AB ser. B Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa HD, a brain metastases solution; Elekta Harmony; and Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs, as well as quality assurance, and treatment and motion management solutions. It also provides stereotactic radiosurgery products, such as Elekta Esprit, a gamma knife system; and Leksell GammaPlan, a treatment planning and management software, as well as Elekta ONE, an oncology software suite. In addition, the company offers brachytherapy products, including Elekta Studio, an image-guided brachytherapy solution; ImagingRing for dynamic imaging; Oncentra Brachy, a smart tool that facilitates repetitive tasks; Elekta Xoft Axxent and electronic brachytherapy systems; Elekta Geneva, an applicator for cervical cancer patients; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Venezia applicator that enables the oncologist to treat locally advanced cervical cancer. Further, it provides Leksell Vantage Stereotactic System, a neurosurgery product; Elekta Kaiku for personalized cancer care; and veterinary radiation therapy solutions. Additionally, the company offers Elekta Care support services; Elekta Care 360, which provides a range of clinical and professional services; Elekta Care Learning that offers in-person and digital training courses on radiotherapy; Elekta Care Community, a self-help center; Elekta Partner Community, an online self-service portal; and Elekta Intellimax for predictive maintenance. Elekta AB (publ) was incorporated in 1972 and is headquartered in Stockholm, Sweden.

Employees
4487
Market
Sweden

Compare EKTAb to Peers and Sector

Metrics to compare
EKTAb
Peers
Sector
Relationship
P/E Ratio
80.0x29.0x−0.5x
PEG Ratio
−0.970.800.00
Price/Book
2.2x2.5x2.6x
Price / LTM Sales
1.1x2.5x3.2x
Upside (Analyst Target)
11.6%26.3%40.5%
Fair Value Upside
Unlock13.9%4.4%Unlock

Analyst Ratings

2 Buy
5 Hold
6 Sell
Ratings:
13 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 58.58
(+17.62% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.62%
Dividend Yield
4.85%
Industry Median 1.56%
Annualised payout
2.40
Paid unevenly
5-Years Growth
+21.67%
Growth Streak

Earnings

Latest Release
May 28, 2025
EPS / Forecast
1.11 / 1.48
Revenue / Forecast
5.16B / 5.31B
EPS Revisions
Last 90 days

EKTAb Income Statement

People Also Watch

65.6800
PRY
-1.23%
32.1600
GASI
+0.12%
7.5930
SAN
+0.21%
43.390
ITX
+0.81%
22.25
STMPA
-1.11%

FAQ

What Stock Exchange Does Elekta AB ser. B Trade On?

Elekta AB ser. B is listed and trades on the Stockholm Stock Exchange stock exchange.

What Is the Stock Symbol for Elekta AB ser. B?

The stock symbol for Elekta AB ser. B is "EKTAb."

What Is the Elekta AB ser. B Market Cap?

As of today, Elekta AB ser. B market cap is 18.38B.

What Is Elekta AB ser. B's Earnings Per Share (TTM)?

The Elekta AB ser. B EPS (TTM) is 0.62.

When Is the Next Elekta AB ser. B Earnings Date?

Elekta AB ser. B will release its next earnings report on 27 Aug 2025.

From a Technical Analysis Perspective, Is EKTAb a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.

How Many Times Has Elekta AB ser. B Stock Split?

Elekta AB ser. B has split 2 times.

How Many Employees Does Elekta AB ser. B Have?

Elekta AB ser. B has 4487 employees.

What is the current trading status of Elekta AB ser. B (EKTAb)?

As of 25 Jul 2025, Elekta AB ser. B (EKTAb) is trading at a price of 49.80, with a previous close of 49.44. The stock has fluctuated within a day range of 49.18 to 49.92, while its 52-week range spans from 44.50 to 76.30.

What Is Elekta AB ser. B (EKTAb) Price Target According to Analysts?

The average 12-month price target for Elekta AB ser. B is SEK58.57692, with a high estimate of SEK108 and a low estimate of SEK39. 2 analysts recommend buying the stock, while 6 suggest selling, leading to an overall rating of Neutral. The stock has an +17.62% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.